(hydroxyprogesterone)

USA: Noting that the drug was ineffective in treating the complication of preterm birth, the US Food and Drug Administration (FDA), in its recent announcement, has decided to withdraw approval of Makena, hydroxyprogesterone caproate injection, and its generic versions. The decision was issued jointly by the FDA Commissioner and Chief Scientist. FDA stated, “Effective from […] More